Featured Research

from universities, journals, and other organizations

New Lab-Made Stem Cells May Be Key To Transplants

Date:

December 27, 2000

Source:

Johns Hopkins Medical Institutions

Summary:

The scientists at Johns Hopkins who, in 1998, showed that human pluripotent stem cells (hPSCs) — humans’ earliest, undifferentiated "full potential" cells — could develop into all the basic types of embryonic tissues that make up human beings, have now "engineered" hPSCs to form a new type of cell that not only holds the potential to develop into different tissues but also overcomes great drawbacks that have limited the use of hPSCs for disease therapy.

Share This

The scientists at Johns Hopkins who, in 1998, showed that human pluripotent stem cells (hPSCs) — humans’ earliest, undifferentiated "full potential" cells — could develop into all the basic types of embryonic tissues that make up human beings, have now "engineered" hPSCs to form a new type of cell that not only holds the potential to develop into different tissues but also overcomes great drawbacks that have limited the use of hPSCs for disease therapy.

Related Articles

The new cells, called embryoid body derived cells (EBDs), "will be the workhorses that carry out the new tissue-transplant therapies," says John D. Gearhart, Ph.D., the Hopkins team leader.

"The first applications of these cells will likely be in Lou Gehrig’s disease (ALS), Type I diabetes, stroke and Parkinson’s disease," says Gearhart. Researchers in other Hopkins labs have already begun testing EBDs on animal models of Lou Gehrig’s and other neurodegenerative diseases, as well as on animal spinal injuries.

EBDs reproduce readily and are easily maintained, Gearhart said, and thus eliminate the need to use fetal tissues each time as a source — a step that should quell many of the political and ethical concerns that swirl around stem cell studies.

"We thought from the first that problems would arise using hPSCs to make replacement tissues," says molecular biologist Michael Shamblott, Ph.D. The early-stage stem cells are both difficult and slow to grow. "More important," says Shamblott, "there’s a risk of tumors.

If you’re not very careful when coaxing these early cells to differentiate — to form nerve cells and the like — you risk contaminating the newly differentiated cells with the stem cells. Injected into the body, stem cells can produce tumors. The EBDs bypass all this."

EBDs readily divide for up to 70 generations, producing millions of cells without any apparent chromosomal abnormalities typical of tumor cells. No tumors appeared in three cancer-prone test mice injected with the new cells.

The researchers began their work with embryonic germ cells, a type of hPSC drawn from discarded fetal tissue. In culture, the germ cells grow into a small mass of cells called an embryoid body. After teasing the embryoid bodies apart using gentle enzymes, the scientists cultured the separated cells in one of six "very simple growth environments."

Sample cells from each environment — now called embryoid body derived cells — were grown again, this time in culture solutions that favored growth of specific cell lines, such as nerve cells, and allowed to divide undisturbed for many generations.

The researchers quickly recognized EBD cells’ ability to grow readily, but hadn’t a clear idea what they’d produced. To their surprise, tests to identify molecules characteristic of specific cell types revealed markers from at least four basic mammalian cell lines, including those that give rise to neural (nerve) cells, muscle and blood.

The researchers believe they have made a sort of biologic raw material which, when placed within specific environments in the body, will be prodded to differentiate into specific tissues.

Geron, Inc. provided funding for the study. Under a licensing agreement between Geron and Johns Hopkins University, the University and John Gearhart and Michael Shamblott are entitled to a share of sales royalty from Geron.

The University and John Gearhart and Michael Shamblott own stock in Geron, the sale of which is subject to certain restrictions under University policy. The terms of this arrangement are being managed by the University in accordance with its conflict-of-interest policies.

Featured Research

Mar. 31, 2015  Researchers have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPAR alpha which activates liver ... full story

Mar. 31, 2015  Researchers have recorded the first direct observations of the micro-scale mechanisms behind the ability of skin to resist tearing. The results could be applied to the improvement of artificial skin, ... full story

Mar. 31, 2015  Fewer than half of the physicians trained in the United States in 2013 received formal education or training on the subject of exercise, according to new research. "There are immense medical benefits ... full story

Mar. 31, 2015  Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, researchers report. "With this treatment, cells under ... full story

Mar. 31, 2015  Increasing state alcohol taxes could prevent thousands of deaths a year from car crashes, say researchers, who found alcohol-related motor vehicle crashes decreased after taxes on beer, wine and ... full story

Mar. 31, 2015  Alcoholism takes a toll on every aspect of a person's life, including skin problems. Now, a new research report helps explain why this happens and what might be done to address it. "The clinical ... full story

Mar. 31, 2015  A new population of 'memory' immune cells has been discovered by scientists, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will ... full story

Mar. 31, 2015  Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying ... full story

Mar. 31, 2015  A new study had researchers seeking answers to why the therapeutic benefit afforded by SSRIs was so limited in children and teenagers. If researchers can uncover the biological mechanisms preventing ... full story

Featured Videos

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015)  The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports.
Video provided by Reuters

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015)  Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline.
Video provided by Washington Post

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015)  Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17
Video provided by AFP

Related Stories

Mar. 14, 2014  A new line of human embryonic stem cells that have the ability to develop into a far broader range of tissues than most existing cell lines has been created by researchers. The cells, called naοve ... full story

Oct. 10, 2013  A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by ... full story

June 11, 2012  Stem cell scientists purified a subset of stem cells found in fat tissue and made from them bone that was formed faster and was of higher quality than bone grown using traditional methods, a finding ... full story

May 18, 2012  Placental stem cells with important therapeutic properties can be harvested in large quantities from the fetal side of human term placentas (called the chorion). The chorion is a part of the ... full story

May 25, 2010  New insight into what stem cells are and how they behave could help scientists to grow cells that form different tissues. A new study has shown that embryonic stem cells consist of cells that switch ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.